TPOB Orphan Consulting

Check out our latest article on LinkedIn

Innovative Strategies for Accelerating Orphan Drug Development and FDA Approval Introduction Orphan drugs are essential for addressing the unmet medical needs of patients suffering from rare diseases. With an estimated 25-30 million Americans affected by approximately 7,000 rare diseases, the development and approval of orphan drugs have become a priority for both pharmaceutica

If you're on LinkedIn, give us a follow 👍

TPOB Orphan Consulting | LinkedIn TPOB Orphan Consulting | 49 followers on LinkedIn. Demystifying & Delivering on Orphan Drug Development & Regulatory | We currently offer the following services from a former FDA Office of Orphan Products Development (OOPD) reviewer with the intent to expand offerings in the future: 1) Orpha...